Market Vectors Biotech ETF is an open-end management investment company. The Fund seeks to replicate the price and yield performance of the Market Vectors U.S. Listed Biotech 25 Index. The fund normally invests at least 80% of its total assets in securities that comprise the benchmark index. The Biotech Index is comprised of common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology industry. Such companies may include small- and medium-capitalization companies and foreign companies that are listed on a U.S. exchange. As of Sept 30 2013, the Fund's total assets were $435,917,620 and its investment portfolio was valued at $434,447,714. We show 76 historical shares outstanding datapoints in our coverage of BBH's shares outstanding history.
Understanding the changing numbers of BBH shares outstanding — and
comprehending the concept of differing number of shares outstanding in general comparing companies like BBH versus peers —
is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies.
Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history.
With this page we aim to empower investors researching BBH by allowing them to research BBH shares outstanding history
as well as any other stock in our coverage universe. |
Video: Shares Outstanding Importance
